Healthcare Pharmaceutical Biotech

Cornerstone Specialty Network and Knowtex Announce Strategic Partnership to Advance AI-Driven Clinical Workflows and Operational Efficiency Nationwide

April 29, 2026 1:40 PM

Cornerstone Specialty Network ("Cornerstone"), a leading national network of community oncology and multispecialty practices, today announced a strategic partnership with Knowtex, a healthcare technology company specializing in voice-enabled AI solutions designed to automate clinical workflows and improve operational performance. Through this partnership, Cornerstone and Knowtex will deploy advanced voice AI technology across the network to...

Read more

IRLAB publishes the Annual Report for 2025

April 29, 2026 10:50 AM

IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announced today that the Annual Report for 2025 is published on the company's website, www.irlab.se. IRLAB has published the Annual Report 2025 for the financial year, which covers January 1 to December 31, 2025. The Annual Report is available, in Swedish, on IRLAB's website: Financial reports - IRLAB. (The Annual Report...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Snapshot Recipes Redesign with Advanced AI, Beverage Integration, and Smart Cookbook Features

April 29, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced a major upgrade to its AI-powered mobile recipe application, Snapshot Recipes, featuring a redesigned user interface, expanded recipe generation capabilities, and enhanced user-focused tools. The latest update introduces a more refined and visually engaging experience, with elegant design improvements aimed at increasing usability, engagement, and overall user...

Read more

CVS Pharmacy Makes Cold & Cough Relief Easier With Delivery Straight to Your Door

April 29, 2026 9:00 AM

Originally published on CVS Health Company News Key points CVS Pharmacy is now offering same-day delivery of over-the-counter medications containing pseudoephedrine (PSE) or ephedrine (EPH) in select states, where allowed by law. The convenient new offering gives customers the ability to purchase cold and cough medicines containing the ingredients online and delivered to their home. Now, more than ever, getting relief doesn't have to mean...

Read more

GAT Sport Introduces Nitraflex(R) Performance Pre-Workout Chews, a Breakthrough Format Designed to Reignite the Pre-Workout Category

April 29, 2026 9:00 AM

GAT Sport (www.gatsport.com), a sports nutrition company trusted by serious athletes for more than 25 years, today announced Nitraflex® Performance Pre-Workout Chews, a new chewable pre-workout tablet designed to deliver powder-level performance through a patent-pending delivery system that may help ingredients take effect faster. Unlike pre-workout and energy drinks that sit in your stomach before kicking in, Nitraflex Performance Pre-Workout...

Read more

KeepWOL Announces Expansion Into Healthcare Following Clinical Collaboration With Academic Medical Center

April 29, 2026 9:00 AM

KeepWOL, an AI-powered team effectiveness platform that helps organizations build belonging and measure team performance, today announced its formal expansion into the healthcare market following a year-long collaboration with a large academic medical center. The platform was deployed in partnership with physician leadership to support an initiative to strengthen belonging and team performance across clinical teams. The expansion comes at a...

Read more

Senzime Strengthens U.S. Operations with New Leadership Appointments

April 29, 2026 8:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced new appointments to its Global Executive Leadership Team, including the recruitment of a new Vice President of U.S. Sales and the appointment of a Vice President of Clinical and Medical Affairs. Josi Wood, MBA, has been recruited to strengthen the company's U.S. commercial operations as Vice President of U.S. Sales, assuming a newly created leadership role within Senzime. Josi is an...

Read more

Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

April 29, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced topline results from the completion of its effectiveness trial of crofelemer (FDA conditionally approved Canalevia-CA1) for the treatment of chemotherapy-induced diarrhea (CID) in dogs. The statistically significant results demonstrated that dogs suffering from CID that were treated with Canalevia-CA1 twice daily at the onset of diarrhea had, at the end of 3 days of treatment, an average...

Read more

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026

April 29, 2026 8:30 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative, patient-centric insulin delivery, today announced that Jeb Besser, CEO of Modular Medical, will present at Tribe Public's Webinar Presentation and Q&A Event titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." The event is scheduled to begin at 8 a.m. pacific / 11 a.m. eastern on Friday, May 1, 2026. To register to join the...

Read more

Shape Ophthalmics Expands Global Access to Advanced Eye Examination Equipment for Eye Care Professionals

April 29, 2026 7:10 AM

Shape Ophthalmics, a leading supplier of ophthalmic and optometry equipment, today announced the continued expansion of its global distribution platform, providing eye care professionals with access to advanced diagnostic technologies across Asia and international markets. Founded by a team of experienced ophthalmologists, optometrists, and opticians, Shape Ophthalmics was established to address the need for a reliable, high-quality source of...

Read more

Evotec SE to Announce First Quarter 2026 Results on May 6, 2026

April 29, 2026 1:50 AM

Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard: EVT) will hold a webcast and conference call to announce its financial results for the first quarter 2026 and provide a business update on Wednesday, May 6, 2026. The conference call will be held in English. Webcast details Date: Wednesday, May 6, 2026 Time: 2.00 pm CEST (12.00 pm GMT, 8.00 am EDT) To join the audio webcast and to access the presentation slides, please register via this link. The...

Read more

Capstone Family Medicine and Alaska Provider Network Lead First-of-Its-Kind Partnership to Transform Rural Healthcare Delivery

April 28, 2026 6:30 PM

Capstone Family Medicine (Capstone), the state's largest rural private practice in primary care, in close collaboration with Alaska Provider Network (APN), today announced a first-of-its-kind strategic partnership with a coalition of national and regional leaders to redefine healthcare delivery across rural Alaska. This alliance includes Electronic Caregiver, Pinnacle Integrated Medicine, Pinnacle Resource Management, Pearl Health, Kachemak...

Read more

Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program

April 28, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announced, further to its news release dated April 21, 2026, the successful scale-up of key intermediates1 A83 and B4, representing an advancement in the Company's chemistry, manufacturing and controls (CMC) program supporting its lead nanoparticle-based PNKP inhibitor drug candidate, ONC010 (also referred to as PNKP Inhibitor Technology)....

Read more

Oak GLP-1 Review - 2026 Updated: Current Pricing, FDA Enforcement Status, and What Patients Are Asking Right Now

April 28, 2026 5:00 PM

Disclosure: This is a sponsored advertorial. This article contains affiliate links - if you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. This article is for informational purposes only and does not constitute medical advice, a diagnosis, a treatment recommendation, or a guarantee of prescription approval,...

Read more

Mindologi Expands Nationwide, Reaching Nearly 500 Providers, as Patent-Pending Platform Advances Mental Health Clarity

April 28, 2026 12:20 PM

Mindologi announced its nationwide expansion within one month of its launch on January 15, 2026, marking a significant early milestone in its rapid growth. The platform expanded across the United States shortly after launch and now works with nearly 500 licensed providers. This early traction reflects increasing demand for faster, more structured pathways to understanding mental health symptoms and accessing appropriate care. Mindologi Logo The...

Read more

Dr. Denaesh Ariyanayagam Calls for Greater Focus on Patient Advocacy and Medical Excellence

April 28, 2026 10:40 AM

Dr. Denaesh Ariyanayagam, a Consultant General and Vascular Surgeon at St. Augustine Private Hospital, is raising awareness around the critical need for patient advocacy, consistent medical standards, and long-term professional discipline in healthcare. With decades of experience in surgery, education, and hospital leadership, Dr. Ariyanayagam is emphasizing that strong healthcare systems begin with individual accountability and a clear focus on...

Read more

Global Nurse Migration Patterns Shift as Europe, Southeast Asia Absorb Growing Share of International Nurses

April 28, 2026 10:00 AM

TruMerit™ (formerly CGFNS International) today released its 2025 Nurse Migration Report, revealing significant shifts in global nurse migration patterns and widening inequities in nursing workforce distribution across regions with vastly different healthcare needs. The report, which analyzes World Health Organization data and TruMerit's proprietary VisaScreen® application records, shows that international nurse migration flows are increasingly...

Read more

Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration

April 28, 2026 9:05 AM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) ("Protagonist" or the "Company") today announced that it has exercised its right to opt out of the 50:50 U.S. profit and loss sharing arrangement under its worldwide license and collaboration agreement with Takeda for rusfertide, an investigational first-in-class hepcidin mimetic peptide under U.S. Food and Drug Administration (FDA) Priority Review for the treatment of adults with polycythemia vera...

Read more

Revecore Launches AI-Powered Underpayment Recovery and Denial Appeals Capabilities

April 28, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced new AI-powered capabilities across underpayment recovery and denial appeals. The announcement comes as hospitals spent nearly $18 billion in 2025 on overturning claims denials alone, according to the American Hospital Association, with no sign the pressure is easing. As health systems navigate rising denial rates, growing...

Read more

CVS Health: What's Next in Treatment: Four Drugs That Could Change Care This Spring

April 28, 2026 9:00 AM

Originally published on CVS Health Company News New treatments take years of research, clinical trials, and regulatory review before reaching patients. Several therapies approaching FDA decisions this spring could expand treatment options for people managing a range of conditions. CVS Caremark's Clinical Pipeline Services team - made up of licensed clinical pharmacists and analysts - monitors new therapies moving through the drug pipeline and...

Read more